COMPANY

About Us

Mavatar was founded in 2018, building on over 20 years of research in precision medicine from the Benson Lab, where foundational research laid the groundwork for our current technology. Over time, we have refined and expanded upon this research, developing unique methods to standardize and integrate diverse data sources, setting us at the forefront of AI-driven precision medicine.

Key company milestones

View our timeline of significant developments for Mavatar as a Company

Go To Newsroom
Johan Juhlin_Davos

23/12/2024 | NEWS

Mavatar at the World Economic Forum in Davos

Mavatar Recognition_1

31/03/2025 | NEWS

Mavatar Recognized as One of Sweden’s Most Exciting AI Health Companies

Screenshot form Mavatar Discovery

27/03/2025 | NEWS

Revolutionizing Disease Research: Introducing Mavatar Discovery™️

Mavatar medicon village Juhlin presents

25/03/2025 | NEWS

Mavatar visits Medicon Village

Johan Juhlin image crossed arms

15/10/2024 | NEWS

Mavatar Secures SEK 40 Million in Partial Funding Round, Advancing its Leadership in AI-Driven Precision Medicine

No image
Image of Linda Wakeham

02/12/2024 | NEWS

Mavatar Strengthens Leadership Team with Linda Wakeham as Head of Marketing & Communication

No image

Decoding disease. Delivering precision.

Mavatar is a global specialist in AI-driven precision medicine. Our mission is to transform healthcare from a reactive, one-size-fits-all approach into predictive, personalized, and highly effective treatments—tailored for every individual across all disease areas.

Built on over 20 years of groundbreaking scientific research, Mavatar integrates advanced AI with deep molecular insights to unlock personalized care's true potential. Our proprietary DINA (Deep Integrated Network Analysis) framework underpins our two flagship platforms:

Mavatar Discovery – Accelerates drug development by unveiling hidden patterns in complex biological data, identifying new therapeutic targets, and optimizing clinical trials.

Mavatar Precision – Provides patient-specific treatment recommendations through AI-powered simulations and digital twins, enabling precise clinical decision-making.

By modeling digital twins of both patients and diseases, we empower researchers and clinicians to make more informed decisions, reducing trial-and-error, lowering healthcare costs, and significantly improving patient outcomes worldwide.

Our Vision

We envision a future where everyone receives personalized, predictive, and effective care, powered by the convergence of biology and artificial intelligence.

Johan Juhlin talking about Mavatar

Our Culture

At Mavatar, our culture thrives on purpose-driven innovation and collaboration. Our diverse team of over 25 specialists, each holding a PhD in data science, bioinformatics, or clinical research, is united by a shared passion for transforming healthcare.

We foster an environment of openness, curiosity, and continuous learning. Our collaborative approach combines rigorous scientific thinking with creative problem-solving, encouraging each team member to contribute bold ideas and challenge conventional wisdom. Integrity, respect, and accountability form the cornerstone of our interactions—both internally and externally.

At Mavatar, we celebrate diverse perspectives and interdisciplinary collaboration, knowing that complex healthcare challenges demand the collective brilliance of many minds. Driven by a shared vision and dedication to impactful innovation, our culture empowers every specialist to grow personally and professionally while making meaningful contributions to healthcare's future.

Mavatar Employees talking in a circle

Mavatar Management Team

Johan Juhlin, CEO & Co-founder
Fredrik Barrenäs, CTO & Co-founder
Danuta Gawel, Chief Research and Development Officer – Precision
Daniel Nilsson, CFO/Legal & Co-founder
Linda Wakeham, Chief Marketing & Communications Officer